The following carboxy-terminal fragment of MUC16 (referred to as MUC16-Cter) has been shown to confer tumorigenic, metastatic, and drug-resistant properties to the pancreatic and lung cancer cells19,27–29. This evidence concerns the gene MUC16 and lung cancer.